Low urgency

US-CONGRESS HR10336: To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.

Detected September 11, 2026 · in Dietary-Supplement Labeling (FDA)

US-CONGRESS HR10336: To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes. — dietary supplement update affecting Dietary-Supplement Labeling (FDA).

Aforeworn detected this change in the Dietary-Supplement Labeling (FDA) space on September 11, 2026 and published this briefing so affected operators are forewarned rather than caught off guard. It is rated Low urgency. Dietary-Supplement Labeling (FDA) (supplement brands) should confirm how it applies to their specific situation before acting. Aforeworn monitors Dietary-Supplement Labeling (FDA) continuously and turns every detected change into a plain-English briefing like this one, so you always know first. Forewarned is forearmed.

What changed

US-CONGRESS HR10336: To amend the Federal Food, Drug, and Cosmetic Act to encourage innovation and increase and protect consumer access with respect to dietary supplements by clarifying the regulatory framework governing drug preclusion, and for other purposes.

Who it affects

Dietary-Supplement Labeling (FDA) (supplement brands)

What you must do

Read the update and assess whether your current setup needs to change.

Deadline

No fixed deadline was published, but changes like this are often enforced quickly — act promptly.

Source: https://www.congress.gov/bill/119th-congress/house-bill/10336

Never miss a change like this again

Aforeworn watches Dietary-Supplement Labeling (FDA) around the clock and alerts you the moment a rule moves — with a plain-English brief on what to do.

Start your free trial

Related changes in Dietary-Supplement Labeling (FDA)